Doctor Chiara Caselli
CNR – National Research Council, Pisa (Italy)
Membership:
ESC Professional Member
Follow
Biography
Chiara Caselli, PhD, is a Senior Researcher at Institute of Clinical Physiology (IFC-CNR). Her research is committed to elucidating the molecular causes of cardiovascular diseases (CVD). As PI or co-Investigator on National- and European-funded grants, Dr. Caselli laid the groundwork for research expertise by elucidating the molecular mechanism of cardiometabolic markers using animal models or in vitro studies, and by establishing their relation with the clinical setting.
Contributor content
Presentation
Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment
Presentation
A specific molecular signature of extra-vesicles (EVs) was associated with cardiometabolic risk profile and atherosclerotic burden in patients with chronic coronary syndrome: a pilot study.
Presentation
Association of serum MMP9 with adverse features of plaque progression in patients with chronic coronary syndrome (CCS).
Presentation
Differential association of high-sensitive cardiac Troponin T and Troponin I with coronary atherosclerotic burden, inducible ischemia and long-term prognosis in patients with chronic coronary syndrome
Presentation
Association of eNOS Glu298Asp polymorphism with cardiometabolic risk and inducible myocardial ischemia in patients with stable coronary artery disease
Presentation
Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina.
Presentation
Elevated TG/HDL-C ratio is an independent predictor of outcome and it is associated with CAD progression in patients with stable coronary artery disease.
Presentation
Low PCSK9 plasma level is an independent predictor of coronary atherosclerotic burden in patients with stable coronary artery disease
Presentation
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study
Presentation
